Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Experts predict that more than a million people could die from liver cancer worldwide in 2040.
Greater political will and financial support for national programs are needed to eliminate viral hepatitis.
Liver cancer is often diagnosed late and it is among the fastest-rising causes of cancer death in the United States.
Plus: Over 10 prevention services related to hepatitis, HIV and sexually transmitted infections covered by the Affordable Care Act.
A study has identified a number of potential biomarkers that clinicians can use to predict how their patients will respond to treatment.
Nearly all HIV-positive study participants achieved protective antibody levels after two doses of Heplisav-B.
Second- and third-generation individuals in Los Angeles had a 35% and 61% higher risk, respectively, than those born in Mexico.
The recent approval of several new medications has changed the treatment landscape.
Insurers should allow co-pay assistance to count as out-of-pocket spending, claims HHS lawsuit by HIV, hepatitis and diabetes advocates.
The risk of HCC fell further as cumulative antihistamine use rose in people with HBV, HCV or both.
Liver cancer is now less likely to be caused by hepatitis B or C, but more likely to be caused by fatty liver disease or alcohol.
Randall N. Hyer, MD, PhD, will continue Blumberg Institute’s hepatitis B and liver cancer research in his new role as president.
Heavy alcohol use among people with hepatitis B or C increased the risk of liver cancer.
Only 30% of U.S. adults have been vaccinated against the liver disease. Here’s how the Hepatitis B Foundation aims to change that.
Screening for hepatitis B virus and liver cancer prevention were promoted through the KakaoTalk app.
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.